Core Insights - Wall Street analysts forecast that Lazard (LAZ) will report quarterly earnings of $0.38 per share, reflecting a year-over-year decline of 26.9%, with anticipated revenues of $688.5 million, showing a slight increase of 0.6% compared to the previous year [1] Earnings Estimates - Over the last 30 days, there has been a downward revision of 1.3% in the consensus EPS estimate for the quarter, indicating a collective reconsideration by covering analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3] Key Metrics Projections - Analysts project 'Adjusted net revenue - Asset Management' at $261.01 million, indicating a year-over-year decline of 1.6% [5] - The estimate for 'Adjusted net revenue - Financial Advisory' is $417.05 million, reflecting a year-over-year increase of 2.2% [5] - 'Adjusted net revenue - Corporate' is expected to reach $9.44 million, suggesting a significant year-over-year decline of 17.8% [5] Assets Under Management - 'Assets under management - Total Fixed Income' is estimated at $45.12 billion, down from $46.11 billion year-over-year [6] - 'Assets under management - Total Equity' is projected to be $182.45 billion, compared to $190.43 billion from the previous year [6] - The estimated 'Assets under management - End of Period' is $236.20 billion, down from $244.67 billion year-over-year, while 'Assets under management - End of Period - Other' is expected to reach $8.64 billion, up from $8.13 billion [7] Stock Performance - Lazard shares have increased by 16.4% in the past month, outperforming the Zacks S&P 500 composite, which rose by 5.9% [7] - With a Zacks Rank 3 (Hold), LAZ is expected to closely follow overall market performance in the near term [7]

Core Insights - Analysts project Old Republic International (ORI) will announce quarterly earnings of $0.79 per share, a 4% increase year over year, with revenues expected to reach $2.17 billion, reflecting a 7.6% increase from the same quarter last year [1] Earnings Projections - Revisions to earnings projections are crucial for predicting investor behavior, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock performance [2] Key Metrics Estimates - Analysts estimate 'Operating Revenue- Specialty Insurance Segment- Net premiums earned' at $1.27 billion, indicating a 12.7% year-over-year increase [4] - 'Operating Revenue- Specialty Insurance Segment- Net investment income' is projected to be $149.75 million, also reflecting a 12.7% increase year over year [4] - 'Operating Revenue- Specialty Insurance Segment- Other income' is expected to reach $47.05 million, showing a slight increase of 0.1% [5] - 'Operating Revenue- Corporate & Other' is estimated at $15.07 million, suggesting a significant decline of 35.3% year over year [5] Title Insurance Segment Estimates - 'Operating Revenue- Title Insurance Segment- Net investment income' is forecasted at $16.44 million, a 6% increase from the prior year [6] - 'Operating Revenue- Title Insurance Segment' is expected to be $693.19 million, indicating a 2.1% year-over-year increase [7] Ratios and Performance Metrics - The 'Specialty Insurance Segment - Loss Ratio' is predicted to be 65.0%, up from 64.3% in the same quarter last year [7] - The 'Specialty Insurance Segment - Expense Ratio' is estimated at 28.6%, compared to 28.1% a year ago [7] - The 'Title Insurance Segment - Combined Ratio' is expected to be 96.8%, up from 95.4% in the previous year [8] - The 'Title Insurance Segment - Expense Ratio' is projected at 94.5%, compared to 93.1% last year [8] - The 'Specialty Insurance Segment - Combined Ratio' is estimated at 93.6%, compared to 92.4% a year ago [9] Stock Performance - Over the past month, Old Republic shares have recorded a return of -1.3%, while the Zacks S&P 500 composite has increased by 5.4% [10]

Core Insights - PepsiCo reported $22.73 billion in revenue for the quarter ended June 2025, a year-over-year increase of 1% [1] - The EPS for the same period was $2.12, down from $2.28 a year ago, with a surprise of +4.43% compared to the consensus estimate of $2.03 [1] Revenue Performance - Net Revenue from the International Beverages Franchise was $1.37 billion, slightly above the average estimate of $1.35 billion [4] - Net Revenue from EMEA was $4.54 billion, exceeding the average estimate of $4.34 billion [4] - Net Revenue from PBNA was $6.8 billion, slightly below the average estimate of $6.84 billion, representing a year-over-year change of -0.2% [4] - Net Revenue from PFNA was $6.48 billion, surpassing the average estimate of $6.4 billion, with a significant year-over-year change of +1054.4% [4] - Net Revenue from LatAm Foods was $2.55 billion, above the average estimate of $2.5 billion, reflecting a year-over-year decline of -16.3% [4] - Net Revenue from Asia Pacific Foods was $1 billion, in line with the average estimate of $1.01 billion [4] Core Operating Profit - Core Operating Profit for PFNA was $1.49 billion, matching the average estimate [4] - Core Operating Profit for PBNA was $994 million, exceeding the average estimate of $916.74 million [4] - Core Operating Profit for the International Beverages Franchise was $538 million, above the average estimate of $512.59 million [4] - Core Operating Profit for Corporate unallocated was -$404 million, worse than the average estimate of -$381.15 million [4] - Core Operating Profit for LatAm Foods was $545 million, surpassing the average estimate of $483.66 million [4] - Core Operating Profit for Asia Pacific Foods was $93 million, below the average estimate of $101.58 million [4] Stock Performance - PepsiCo shares returned +4.9% over the past month, outperforming the Zacks S&P 500 composite's +4.2% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market [3]

Core Insights - Goldman Sachs is expected to report quarterly earnings of $9.43 per share, reflecting a 9.4% increase year-over-year, with revenues projected at $13.5 billion, a 6% increase from the previous year [1] Earnings Estimates - Analysts have revised the consensus EPS estimate 1.1% lower over the last 30 days, indicating a reevaluation of initial forecasts [1][2] - The importance of earnings estimate revisions is highlighted as a predictor of investor actions and stock performance [2] Revenue Projections - Analysts estimate 'Net Revenues- Global Banking & Markets- FICC' to reach $3.39 billion, a year-over-year increase of 6.7% [4] - 'Net Revenues- Asset & Wealth Management- Debt investments' are projected at $151 million, indicating a significant decline of 49.2% from the prior year [4] - 'Net Revenues- Platform Solutions- Consumer platforms' are expected to be $619.93 million, reflecting a 3.5% increase [5] - 'Net Revenues- Global Banking & Markets- Equities' are forecasted at $3.74 billion, showing an 18.2% increase [5] - 'Net Revenues- Asset & Wealth Management- Private banking and lending' is estimated at $744.53 million, a 5.3% increase [6] - 'Net Revenues- Platform Solutions- Transaction banking and other' is expected to be $65.86 million, a decrease of 5.9% [6] - 'Net Revenues- Global Banking & Markets- Advisory' is projected at $891.69 million, a substantial increase of 29.6% [7] - The total 'Net Revenues- Asset & Wealth Management' is estimated at $3.82 billion, a slight decline of 1.5% [7] Key Metrics - The 'Book Value Per Share' is expected to reach $347.76, up from $327.13 in the same quarter last year [8] - 'Assets Under Supervision (AUS) - Total' is forecasted to be $3,228.04 billion, compared to $2,934.00 billion a year ago [8] - The 'Common equity tier 1 capital ratio' is estimated at 15.1%, up from 14.8% year-over-year [8] - The 'Leverage ratio' is expected to be 5.3%, slightly down from 5.4% in the previous year [9] Stock Performance - Goldman Sachs shares have increased by 13.4% over the past month, outperforming the S&P 500 composite, which rose by 4.1% [10]

Financial Performance - HP reported $13.22 billion in revenue for the quarter ended April 2025, a year-over-year increase of 3.3% [1] - The EPS for the same period was $0.71, down from $0.82 a year ago, representing a decline of 13.4% [1] - The reported revenue was a surprise of -1.51% compared to the Zacks Consensus Estimate of $13.42 billion [1] - The EPS surprise was -11.25% against the consensus estimate of $0.80 [1] Key Metrics - Days in accounts payable were 130 days, better than the two-analyst average estimate of 134 days [4] - Days of sales outstanding in accounts receivable were 30 days, slightly above the average estimate of 29 days [4] - Days of supply in inventory were 70 days, compared to the average estimate of 73.5 days [4] Revenue Breakdown - Net revenue from Personal Systems - Commercial PS was $6.79 billion, below the average estimate of $6.99 billion, with a year-over-year change of +8.7% [4] - Net revenue from Personal Systems - Consumer PS was $2.24 billion, slightly above the average estimate of $2.20 billion, representing a +2.5% year-over-year change [4] - Total net revenue from Personal Systems was $9.02 billion, below the average estimate of $9.19 billion, with a +7.1% year-over-year change [4] - Net revenue from Printing - Supplies was $2.73 billion, slightly below the average estimate of $2.75 billion, reflecting a -4.9% year-over-year change [4] - Net revenue from Printing - Commercial Printing was $1.17 billion, below the average estimate of $1.19 billion, with a -3.2% year-over-year change [4] - Net revenue from Printing - Consumer Printing was $289 million, slightly above the average estimate of $287.61 million, representing a -3.3% year-over-year change [4] - Total net revenue from Printing was $4.18 billion, below the average estimate of $4.23 billion, reflecting a -4.3% year-over-year change [4] Operational Earnings - Earnings from operations in Printing were $814 million, exceeding the average estimate of $795.04 million [4] - Earnings from operations in Personal Systems were $409 million, below the average estimate of $532.89 million [4] Stock Performance - HP shares returned +11.1% over the past month, outperforming the Zacks S&P 500 composite's +7.4% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance in the near term [3]

Core Viewpoint - Hub Group reported a revenue of $915.22 million for the quarter ended March 2025, reflecting an 8.4% year-over-year decline and a surprise of -5.27% compared to the Zacks Consensus Estimate of $966.14 million [1] Group 1: Financial Performance - Earnings per share (EPS) for the quarter was $0.44, unchanged from the previous year, with an EPS surprise of +4.76% against the consensus estimate of $0.42 [1] - The company’s shares have returned -10.4% over the past month, contrasting with the Zacks S&P 500 composite's +11.3% change, indicating potential underperformance in the near term [3] Group 2: Revenue Breakdown - Operating Revenue from Intermodal and Transportation Solutions was $530.02 million, below the average estimate of $561.23 million, representing a year-over-year decline of 4% [4] - Operating Revenue from Inter-segment eliminations was -$25.81 million, better than the estimated -$28.63 million, but still reflecting a significant year-over-year change of -21.2% [4] - Operating Revenue from Logistics was $411 million, also below the average estimate of $446.60 million, marking a year-over-year decline of 14.4% [4]

Core Insights - Crocs reported revenue of $937.33 million for Q1 2025, a slight year-over-year decline of 0.1%, with EPS at $3.00 compared to $3.02 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $909.56 million by 3.05%, and the EPS surpassed the consensus estimate of $2.51 by 19.52% [1] Revenue Breakdown - Crocs Brand revenue was $761.61 million, exceeding the average estimate of $744.37 million, reflecting a year-over-year increase of 2.4% [4] - HEYDUDE Brand revenue was $175.73 million, below the average estimate of $166.55 million, showing a year-over-year decline of 9.8% [4] - Direct-to-Consumer revenue for Crocs Brand was $284.80 million, slightly above the estimate of $279.37 million [4] - HEYDUDE Brand Direct-to-Consumer revenue reached $65.03 million, surpassing the estimate of $61.63 million [4] - Wholesale revenue for Crocs Brand was $476.80 million, exceeding the estimate of $467.14 million [4] - HEYDUDE Brand Wholesale revenue was $110.69 million, above the estimate of $105.40 million [4] Margin Analysis - Non-GAAP Gross Margin for HEYDUDE Brand was 46.6%, lower than the estimated 47.9% [4] - Non-GAAP Gross Margin for Crocs Brand was 60.7%, higher than the estimated 58.3% [4] Stock Performance - Crocs shares returned +1.2% over the past month, underperforming the Zacks S&P 500 composite's +11.3% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance in the near term [3]

Core Viewpoint - Analysts expect Alcon to report quarterly earnings of $0.76 per share, reflecting a year-over-year decline of 2.6%, with revenues projected at $2.51 billion, an increase of 2.7% from the previous year [1] Earnings Estimates - There have been no revisions in the consensus EPS estimate for the quarter over the last 30 days, indicating stability in analysts' forecasts [1][2] Key Metrics Projections - Analysts estimate 'Net Sales- Total Surgical' to be $1.38 billion, representing a year-over-year increase of 2.8% [3] - The forecast for 'Net Sales- Total Vision Care' is $1.14 billion, indicating a year-over-year change of 2.7% [4] - 'Net Sales- Total Surgical- Consumables' is projected to reach $717.01 million, reflecting a 4.5% increase from the prior year [4] - 'Net Sales- Total Surgical- Equipment/other' is expected to be $223.04 million, showing a 1.8% year-over-year change [4] - 'Net Sales- Total Vision Care- Contact lenses' is anticipated to be $693.41 million, indicating a 3.3% increase from the previous year [5] - 'Net Sales- Total Vision Care- Ocular health' is projected at $441.87 million, reflecting a year-over-year change of 1.6% [5] - 'Net Sales- Total Surgical- Implantables' is expected to reach $435.74 million, indicating a 0.6% increase from the prior year [6] - The consensus for 'Revenues- Other revenues' stands at $17.50 million, reflecting a significant year-over-year increase of 16.7% [6] - 'Net sales by region- International' is projected to be $1.39 billion, indicating a 7.4% increase from the previous year [6] Stock Performance - Alcon shares have increased by 6.8% over the past month, compared to an 11.3% increase in the Zacks S&P 500 composite, with a Zacks Rank of 3 (Hold), suggesting expected performance in line with the overall market [7]

Core Insights - Charles River Laboratories International, Inc. (CRL) reported first-quarter 2025 adjusted earnings per share (EPS) of $2.34, a 3.1% increase year over year, exceeding the Zacks Consensus Estimate by 13.6% [1] - Total revenues for the first quarter reached $984.2 million, surpassing the Zacks Consensus Estimate by 5.2%, but reflecting a 2.4% decline from the previous year [2] - The company raised its 2025 guidance, indicating improved net bookings in the Discovery and Safety Assessment (DSA) segment [12] Financial Performance - The gross profit for the quarter was $317.7 million, down 7.9% from the prior year, with a gross margin of 32.3%, contracting 181 basis points year over year [7] - Selling, general & administrative expenses decreased by 4.6% year over year to $177.8 million, while adjusted operating profit fell 11.7% to $139.9 million [7] - The company exited the first quarter with cash and cash equivalents of $229.4 million, an increase from $194.6 million at the end of the previous quarter [8] Segment Performance - Research Models and Services (RMS) revenues totaled $213.1 million, down 3.5% year over year, primarily due to timing of shipments in China and lower revenues in the Cell Solutions business [4] - Discovery and Safety Assessment (DSA) revenues amounted to $592.6 million, a decline of 2.1% year over year, attributed to lower revenues for discovery services [5] - Manufacturing Solutions revenues were $178.5 million, down 3.6% year over year, mainly due to declines in CDMO and Biologics Testing businesses [6] Shareholder Returns - During the first quarter, the company repurchased 2.1 million shares for a total of $350 million, with a remaining authorization of $549.3 million under its $1 billion stock repurchase program [9] 2025 Guidance - For 2025, CRL expects total revenues to decline in the range of 5.5%-3.5%, an improvement from the earlier estimate of 4.5%-7% [10] - Adjusted EPS for 2025 is projected to be in the range of $9.30-$9.80, up from the previous range of $9.10-$9.60 [11]

Core Viewpoint - Wall Street analysts anticipate EPR Properties will report quarterly earnings of $1.19 per share, reflecting a year-over-year increase of 6.3%, with revenues expected to reach $146.95 million, up 3.3% from the previous year [1]. Group 1: Earnings Estimates - The consensus EPS estimate has been revised 0.8% higher over the last 30 days, indicating a collective reevaluation by analysts [1]. - The consensus estimate for 'Depreciation and amortization' is projected at $40.71 million, slightly up from $40.47 million year-over-year [5]. Group 2: Revenue Projections - Analysts expect 'Revenue- Rental revenue' to be $146.95 million, indicating a 3.3% year-over-year increase [4]. - 'Revenue- Mortgage and other financing income' is estimated at $15.03 million, reflecting a 16.4% increase from the year-ago quarter [4]. - 'Revenue- Other income' is forecasted to reach $28.60 million, suggesting a significant year-over-year change of 137.6% [4]. Group 3: Market Performance - Over the past month, shares of EPR Properties have returned +9.8%, compared to the Zacks S&P 500 composite's +11.5% change [6]. - EPR Properties currently holds a Zacks Rank 2 (Buy), indicating potential outperformance in the near future [6].